The relation between microalbuminuria and coronary collateral vessel development in patients with unstable coronary

Ramazan Topsakal1, Mehmet G Kaya, Mustafa Duran

  • 1Department of Cardiology, Erciyes University School of Medicine, Kayseri, Turkey.

Coronary Artery Disease
|August 26, 2009
PubMed

Insights

Microalbuminuria, a marker of vascular disease, is linked to poorer coronary collateral vessel development in unstable coronary artery disease patients. This finding suggests microalbuminuria negatively impacts cardiovascular health.

Area of Science:

  • Cardiology
  • Nephrology
  • Vascular Biology

Background:

  • Microalbuminuria is a marker for systemic vascular disease and predicts cardiovascular risk.
  • The specific relationship between microalbuminuria and coronary collateral vessel (CCV) development is not well understood.
  • Unstable coronary artery disease (USCAD) presents a critical context for investigating cardiovascular markers.

Purpose of the Study:

  • To investigate the association between microalbuminuria and CCV development in patients with USCAD.
  • To determine if microalbuminuria impacts the formation of coronary collateral vessels in non-diabetic, non-hypertensive USCAD patients.
  • To clarify the role of microalbuminuria as a potential indicator of impaired vascular adaptation in coronary artery disease.

Main Methods:

  • Radioimmunoassay measurement of microalbuminuria in 24-hour urine collections.
  • Coronary angiography to assess coronary artery stenosis and CCV development (Rentrop score >= 1).
  • Comparative analysis between a microalbuminuria group (n=26) and a normoalbuminuria control group (n=80) of USCAD patients.

Main Results:

  • CCV development was observed in 23% of patients with microalbuminuria versus 74% in the normoalbuminuria group.
  • A significant inverse correlation was found between microalbuminuria and CCV development (r = -0.15, P = 0.006).
  • Patients with microalbuminuria demonstrated significantly poorer CCV development compared to those with normoalbuminuria.

Conclusions:

  • Microalbuminuria is associated with impaired coronary collateral vessel development in patients with unstable coronary artery disease.
  • These findings suggest that microalbuminuria negatively influences the body's ability to form compensatory blood vessels in the context of coronary artery disease.
  • Microalbuminuria may serve as a relevant biomarker for assessing vascular health and collateralization capacity in USCAD patients.

Related Concept Videos

Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
Diabetic Nephropathy01:28

Diabetic Nephropathy

Definition Diabetic nephropathy is a chronic kidney complication that results from prolonged hyperglycemia.Prevalence It is the most common cause of chronic kidney disease (CKD) and end-stage renal disease (ESRD) worldwide, affecting up to half of individuals with diabetes.Pathophysiology • Sustained hyperglycemia triggers multiple hemodynamic and metabolic changes in the kidney. • Early in the disease, increased renal blood flow and glomerular hyperfiltration occur due to afferent arteriolar...
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...